GLI1 and mesothelioma: Targeting the Hh pathway either through RNA-interference knockdown of GLI1 and GLI2 or using Gli inhibitors, has been shown to induce growth inhibition and cell death in mesothelioma cells and xenograft tumors in vivo [13, 21, 22].